press information / news

Auszeichnung

Two honoray doctorates for Martin Hrabě de Angelis

Not one but two prestigious German universities recently awarded an honorary doctorate to Prof. Dr. Dr. h.c. Martin Hrabě de Angelis from the Helmholtz Zentrum München and the Technische Universität München: First the genetics expert received an "Honorary Doctorate in Veterinary Medicine" from the Ludwig-Maximilians-Universität Faculty of Veterinary Medicine at the end of July. On 22 October 2018 he was awarded an honoray doctorate by the Technische Universität Dresden Faculty of Medicine.

Prof. Dr. Dr. h.c. Martin Hrabě de Angelis © André Wirsig/ Universitätsklinikum Carl Gustav Carus an der TU Dresden

Ludwig-Maximilians-Universität paid tribute particularly to his contributions in the field of functional genomics and diabetes research. In the last 10 years, Professor Hrabě de Angelis has been involved in numerous joint research projects, scientific collaborations and joint publications in the field of diabetes research for the Universität Dresden, it says in the announcement of the ceremony on 22 October 2018. "He was also able to make a major contribution to the development and perpetuation of the TU Dresden Faculty of Medicine in building up and maintaining excellence."

Martin Hrabě de Angelis is a leading international geneticist. He has headed the Institute of Experimental Genetics (IEG) at the Helmholtz Zentrum München since 2000 and has held the Chair for Experimental Genetics at the Technische Universität München since 2003. He is also the director of the European INFRAFRONTIER research infrastructure. In 2001 he founded the German Mouse Clinic (GMC) for the systemic analysis of models for human diseases. Prof. Hrabě de Angelis has published more than 500 original works and is the author of a number of textbooks. He manages research projects at the international level and is co-founder and board member of the German Center for Diabetes Research (DZD) which was established in 2009. Hrabě de Angelis is a member of the National Academy of Sciences, the Leopoldina.

Martin Hrabě de Angelis studied biology at Philipps-Universität in Marburg and completed his PhD on the influence of growth factors on early embryonic development in 1994. During his time as a postdoctoral researcher (1994-1997) at Jackson Laboratory in Bar Harbor, Maine (USA), he investigated the delta/notch signaling pathway and mouse models in somitogenesis.

Further information:

Background:
You can find a comprehensive portrait of Martin Hrabě de Angelis on the Helmholtz Zentrum München website.

As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus, allergies and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members. 

The research objective of the Institute of Experimental Genetics (IEG) is to elucidate the causes and pathogenesis of human diseases. Due to its prominent role in interdisciplinary and international consortia, the IEG is a global leader in the systemic study of mouse models for human diseases and the elucidation of involved genes. The main focus is on metabolic diseases such as diabetes. The IEG is part of the Helmholtz Diabetes Center (HDC).

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.